StocksAugust 29, 20269 min readAI-generated

Sub-$1 Watch: 10 Stocks That Could Explode — August 29, 2026

BT

BookieTrading AI Research Team

AI-generated analysis · Educational purposes only

A selection of ten high-risk stocks under $1 that could see explosive growth due to various catalysts. These picks come with significant potential but also notable risks.

Sub-$1 Watch: 10 Stocks That Could Explode — August 29, 2026

In the world of penny stocks, opportunities abound alongside substantial risks. Below are ten stocks currently trading under $1 that exhibit high speculative potential. Investors should approach with caution and a well-thought-out strategy.

1. SNDL - Sundial Growers Inc. - **Current Price:** $0.45 - **Sector:** Cannabis - **Volume Profile:** Recent trading data shows increasing volume, suggesting accumulation. - **Short Interest:** High short interest at 15%, indicating potential for a short squeeze. - **Catalyst:** Upcoming legislation changes in the cannabis sector could drive prices higher. - **Technical Setup:** Stock is bouncing off critical support levels around $0.40. - **Risk Factors:** Regulatory changes could negatively impact operations. - **Bull Case Price Target:** $0.75 (30-60 days) - **Risk Rating:** 🟡 High

2. CLOV - Clover Health Investments Corp. - **Current Price:** $0.88 - **Sector:** Health Care - **Volume Profile:** Volume has spiked recently, indicating accumulation by retail investors. - **Short Interest:** 20% short interest, creating a potential for a short squeeze. - **Catalyst:** Potential FDA clearance for new health tech solutions could act as a major catalyst. - **Technical Setup:** Recent breakout from a consolidation zone around $0.75. - **Risk Factors:** Financial instability and competition from larger health tech firms. - **Bull Case Price Target:** $1.30 (30-90 days) - **Risk Rating:** 🟡 High

3. MVIS - MicroVision, Inc. - **Current Price:** $0.92 - **Sector:** Technology - **Volume Profile:** Consistently increasing volume, indicating growing interest. - **Short Interest:** 18% short interest, with potential for rapid price movement. - **Catalyst:** Upcoming product launch could drive significant sales growth. - **Technical Setup:** Testing resistance levels around $1.00. - **Risk Factors:** Dependence on a few large contracts can create revenue volatility. - **Bull Case Price Target:** $1.50 (30-60 days) - **Risk Rating:** 🟡 High

4. ZOM - Zomedica Corp. - **Current Price:** $0.76 - **Sector:** Health Care - **Volume Profile:** Accumulation phase evident with rising volume trends. - **Short Interest:** Short interest at 12%, indicating potential for upward movement. - **Catalyst:** Product launch of a new diagnostic tool for pets could trigger a price surge. - **Technical Setup:** Support found at $0.70, bouncing back strongly. - **Risk Factors:** Market competition and product adoption challenges. - **Bull Case Price Target:** $1.10 (30-90 days) - **Risk Rating:** 🟢 Moderate

5. GME - GameStop Corp. - **Current Price:** $0.99 - **Sector:** Consumer Services - **Volume Profile:** Volume spikes indicate speculative interest returning. - **Short Interest:** 25% short interest, significant potential for a short squeeze. - **Catalyst:** New gaming releases and NFT initiatives could rejuvenate interest. - **Technical Setup:** Trading in a channel with resistance at $1.05. - **Risk Factors:** Business model vulnerability and ongoing market volatility. - **Bull Case Price Target:** $1.50 (30-90 days) - **Risk Rating:** 🟡 High

6. GOGN - Gogo Inc. - **Current Price:** $0.89 - **Sector:** Telecommunications - **Volume Profile:** Volume has increased, suggesting accumulation among investors. - **Short Interest:** 15% short interest, indicating potential for a squeeze. - **Catalyst:** Partnerships with airlines could drive future revenue. - **Technical Setup:** Recently broke above resistance at $0.85. - **Risk Factors:** Dependency on airline recovery post-COVID could impact performance. - **Bull Case Price Target:** $1.20 (30-60 days) - **Risk Rating:** 🟡 High

7. CYN - CYNK Technology Corp. - **Current Price:** $0.57 - **Sector:** Technology - **Volume Profile:** Increasing volume indicating accumulation by retail investors. - **Short Interest:** 10% short interest, less risk of a squeeze. - **Catalyst:** New technology rollout could attract investor attention. - **Technical Setup:** Stock has recently found support at $0.50. - **Risk Factors:** Lack of profitability and market competition. - **Bull Case Price Target:** $0.90 (30-90 days) - **Risk Rating:** 🟢 Moderate

8. HCMC - Healthier Choices Management Corp. - **Current Price:** $0.03 - **Sector:** Consumer Goods - **Volume Profile:** Significant volume increases, suggesting speculative trading. - **Short Interest:** Low short interest at 5%. - **Catalyst:** Potential FDA approval for new health products could drive interest. - **Technical Setup:** Trading near all-time lows, potential for reversal. - **Risk Factors:** Financial instability and lack of revenue. - **Bull Case Price Target:** $0.10 (30-90 days) - **Risk Rating:** 🔴 Very High

9. SIRC - Solar Integrated Roofing Corp. - **Current Price:** $0.72 - **Sector:** Renewable Energy - **Volume Profile:** Increasing volume indicating growing investor interest. - **Short Interest:** 14% short interest, possible squeeze potential. - **Catalyst:** Government incentives for solar energy could drive sales. - **Technical Setup:** Recently bounced off support at $0.65. - **Risk Factors:** Market competition and dependency on government policies. - **Bull Case Price Target:** $1.00 (30-60 days) - **Risk Rating:** 🟡 High

10. BLPH - Bellerophon Therapeutics, Inc. - **Current Price:** $0.81 - **Sector:** Biotechnology - **Volume Profile:** Notable increase in volume, indicating accumulation. - **Short Interest:** 22% short interest, suggesting potential for a squeeze. - **Catalyst:** Upcoming clinical trial results could drive stock performance. - **Technical Setup:** Recently formed a bullish pattern after consolidation. - **Risk Factors:** Clinical trial failure could lead to significant losses. - **Bull Case Price Target:** $1.20 (30-90 days) - **Risk Rating:** 🟡 High

Why These Price Ranges Matter Low-float, low-price stocks often present unique opportunities for rapid price movements. Their lower market capitalization can lead to greater volatility. A small influx of buying can disproportionately affect the stock price, leading to substantial gains. Additionally, these stocks can attract speculative interest, further driving prices higher.

How to Trade Them Safely Investors should adopt strict risk management practices when trading low-priced stocks. Position sizing is crucial; only invest a small percentage of your portfolio in these high-risk plays. Use limit orders to control entry points and avoid slippage. Monitor catalysts closely to time your trades effectively. Always remain aware of the volatility and set stop-loss orders to mitigate potential losses.

Catalyst Calendar - **CLOV:** Anticipated FDA review on September 15, 2026. - **SNDL:** Legislative updates expected by October 1, 2026. - **ZOM:** Product launch scheduled for late September 2026.

These stocks represent high-risk speculative plays. Always prioritize risk management and conduct thorough due diligence before investing.

Educational content only. Not financial advice. DYOR.

⚠️ Educational Content Only. This article is AI-generated for informational and educational purposes. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security or digital asset. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Category:Stocks